Neoadjuvant treatment of HER2-positive breast cancer – pathological complete response (pCR) as a surrogate of long term outcomes in the context of regulatory guidelines and reimbursement recommendations. Journal title: JOURNAL OF HEALTH POLICY & OUTCOMES RESEARCH Authors: Anna Panasiuk, Dariusz Pawlik, Małgorzata Budasz-Świderska, Marcin Kaczor Subject(s):
Predictive Importance of Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio for Pathologic Complete Response in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Journal title: International Journal of Current Research and Review Authors: Caglayan Geredeli Subject(s):
